Favipiravir-抑制剂-深圳欣博盛生物科技有限公司

首页产品中心抑制剂

Favipiravir

品牌：Adipogen

官网链接

说明书

折扣/货期

货号：AG-CR1-3717-M005	规格：5 mg	目录价：￥360
货号：AG-CR1-3717-M025	规格：25 mg	目录价：￥540
货号：AG-CR1-3717-M100	规格：100 mg	目录价：￥1320

产品详情

* 以下信息仅供参考，详情请以原厂网站为准

产品名称:

Favipiravir

别名:

6-Fluoro-3,4-dihydro-3-oxo-2-pyrazinecarboxamide; Favilavir; T-705; Avigan

产品描述:

The guanine analog Favipiravir is a broad spectrum inhibitor of viral RNA polymerase, acting on viral genetic copying to prevent its reproduction. Favipiravir is a prodrug that is metabolized to its active form, favipiravir-ribofuranosyl-5'-triphosphate (Favipiravir-RTP), which inhibits selectively RNA-dependent RNA polymerase (RdRp) in RNA viruses. This antiviral agent inhibits influenza A, B and C without inducing cytotoxicity up to 1,000 µg/ml. It also inhibits influenza strains resistant to current antiviral drugs and shows a synergistic effect in combination with oseltamivir (Prod. No. AG-CR1-3714), thereby expanding influenza treatment options. Favipiravir is active against a variety of additional viruses, including West Nile virus, yellow fever virus, foot-and-mouth disease virus as well as other flaviviruses, arenaviruses, bunyaviruses and alphaviruses in vitro and in vivo. Activity has also been shown against enteroviruses, Rift Valley fever virus and Marburg virus (MARV9), while limited efficacy has been shown against Ebola virus (EBOV) and Zika virus in animal studies. Favipiravir shows potential efficacy against SARS-CoV-2 and is undergoing clinical studies to test its efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19).

保存温度:

+4°C

运输温度:

Ambient

预期分子量:

157.1

产品形式:

solid

产地:

瑞士

纯度:

>98%